SCHEMBL2432798

SCHEMBL2432798

O=c1c(O)cn(-c2cccc(-c3ccccc3)c2)cc1OBOc1cn(-c2cccc(-c3ccccc3)c2)cc(O)c1=O

nearest known ligand 0.61

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
COMT P21964 14/20 0.61
FAAH O00519 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HSP90AA1 P07900 1/20 0.40
PKM P14618 1/20 0.40
HTT P42858 1/20 0.40
ATM Q13315 1/20 0.40
MGLL Q99685 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
TET2 Q6N021 1/20 0.34
TET1 Q8NFU7 1/20 0.34
ACMSD Q8TDX5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2432796 0.76 COMT (1.00) COMTFAAHALDH1A1HSP90AA1PKM
SCHEMBL2463252 0.72 COMT (1.00) COMTFAAHALDH1A1HSP90AA1PKM
SCHEMBL6900197 0.67 COMT (0.52) COMT
SCHEMBL14471451 0.66 COMT (0.63) COMT
SCHEMBL2469729 0.66 MAPK14 (0.43) COMTFAAHALDH1A1HSP90AA1PKM
SCHEMBL2467409 0.63 COMT (1.00) COMTFAAHALDH1A1HSP90AA1PKM
SCHEMBL14816337 0.62 COMT (0.60) COMTFAAHALDH1A1HSP90AA1PKM
SCHEMBL6900202 0.62 COMT (0.60) COMTFAAHALDH1A1HSP90AA1PKM
SCHEMBL2464097 0.62 COMT (0.58) COMTFAAHALDH1A1HSP90AA1PKM
SCHEMBL27479253 0.62 COMT (0.54) COMTFAAHALDH1A1HSP90AA1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2542076-A1 INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS Merck Sharp & Dohme Corp. (US) 2013-01-09 EP disclosed
WO-2011109254-A1 INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS MERCK SHARP & DOHME CORP. (US) 2011-09-09 WO disclosed